Global Plasma Fractionation market will register a 3.8% CAGR in terms of revenue, the market size will reach USD 29.6 Billion by 2024, from USD 24.6 Billion in 2019.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Plasma Fractionation is widely used for Immunology, Hematology and Other. The most proportion of Plasma Fractionation is for Immunology, and the proportion is about 28% in 2017.
North America is the largest sales place, with a consumption value market share nearly 39.85% in 2017. Following North America, Europe is the second largest sales place with the revenue market share of 25.52% in 2017. China is an important market of Blood Product in Asia, accounting for 14.42% revenue market share of global market.
Baxter, CSL, Grifols are the leaders of the industry, with 71.6% market share in 2017, and hold key technologies and patents. Other manufactures鈥� products are used to meet local demand. With further expanding market, there will be more players in the future.
According to this study, over the next five years the Plasma Fractionation market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 29600 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global revenue market share of key companies in Plasma Fractionation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Plasma Fractionation market by product type, application, key companies and key regions.
This study considers the Plasma Fractionation value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Albumin
Immune Globulin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Immunology
Hematology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Plasma Fractionation market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plasma Fractionation market by identifying its various subsegments.
Focuses on the key global Plasma Fractionation players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Fractionation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Plasma Fractionation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.
Table of Contents
2019-2024 Global Plasma Fractionation 麻豆原创 Report (Status and Outlook)
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Plasma Fractionation 麻豆原创 Size 2014-2024
2.1.2 Plasma Fractionation 麻豆原创 Size CAGR by Region
2.2 Plasma Fractionation Segment by Type
2.2.1 Albumin
2.2.2 Immune Globulin
2.2.3 Coagulation Factor
2.3 Plasma Fractionation 麻豆原创 Size by Type
2.3.1 Global Plasma Fractionation 麻豆原创 Size 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Plasma Fractionation 麻豆原创 Size Growth Rate by Type (2014-2019)
2.4 Plasma Fractionation Segment by Application
2.4.1 Immunology
2.4.2 Hematology
2.4.3 Other
2.5 Plasma Fractionation 麻豆原创 Size by Application
2.5.1 Global Plasma Fractionation 麻豆原创 Size 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Plasma Fractionation 麻豆原创 Size Growth Rate by Application (2014-2019)
3 Global Plasma Fractionation by Players
3.1 Global Plasma Fractionation 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Plasma Fractionation 麻豆原创 Size by Players (2017-2019)
3.1.2 Global Plasma Fractionation 麻豆原创 Size 麻豆原创 Share by Players (2017-2019)
3.2 Global Plasma Fractionation Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Plasma Fractionation by Regions
4.1 Plasma Fractionation 麻豆原创 Size by Regions
4.2 Americas Plasma Fractionation 麻豆原创 Size Growth
4.3 APAC Plasma Fractionation 麻豆原创 Size Growth
4.4 Europe Plasma Fractionation 麻豆原创 Size Growth
4.5 Middle East & Africa Plasma Fractionation 麻豆原创 Size Growth
5 Americas
5.1 Americas Plasma Fractionation 麻豆原创 Size by Countries
5.2 Americas Plasma Fractionation 麻豆原创 Size by Type
5.3 Americas Plasma Fractionation 麻豆原创 Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Plasma Fractionation 麻豆原创 Size by Countries
6.2 APAC Plasma Fractionation 麻豆原创 Size by Type
6.3 APAC Plasma Fractionation 麻豆原创 Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Plasma Fractionation by Countries
7.2 Europe Plasma Fractionation 麻豆原创 Size by Type
7.3 Europe Plasma Fractionation 麻豆原创 Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Plasma Fractionation by Countries
8.2 Middle East & Africa Plasma Fractionation 麻豆原创 Size by Type
8.3 Middle East & Africa Plasma Fractionation 麻豆原创 Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends
10 Global Plasma Fractionation 麻豆原创 Forecast
10.1 Global Plasma Fractionation 麻豆原创 Size Forecast (2019-2024)
10.2 Global Plasma Fractionation Forecast by Regions
10.2.1 Global Plasma Fractionation Forecast by Regions (2019-2024)
10.2.2 Americas 麻豆原创 Forecast
10.2.3 APAC 麻豆原创 Forecast
10.2.4 Europe 麻豆原创 Forecast
10.2.5 Middle East & Africa 麻豆原创 Forecast
10.3 Americas Forecast by Countries
10.3.1 United States 麻豆原创 Forecast
10.3.2 Canada 麻豆原创 Forecast
10.3.3 Mexico 麻豆原创 Forecast
10.3.4 Brazil 麻豆原创 Forecast
10.4 APAC Forecast by Countries
10.4.1 China 麻豆原创 Forecast
10.4.2 Japan 麻豆原创 Forecast
10.4.3 Korea 麻豆原创 Forecast
10.4.4 Southeast Asia 麻豆原创 Forecast
10.4.5 India 麻豆原创 Forecast
10.4.6 Australia 麻豆原创 Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany 麻豆原创 Forecast
10.5.2 France 麻豆原创 Forecast
10.5.3 UK 麻豆原创 Forecast
10.5.4 Italy 麻豆原创 Forecast
10.5.5 Russia 麻豆原创 Forecast
10.5.6 Spain 麻豆原创 Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt 麻豆原创 Forecast
10.6.2 South Africa 麻豆原创 Forecast
10.6.3 Israel 麻豆原创 Forecast
10.6.4 Turkey 麻豆原创 Forecast
10.6.5 GCC Countries 麻豆原创 Forecast
10.7 Global Plasma Fractionation Forecast by Type
10.8 Global Plasma Fractionation Forecast by Application
11 Key Players Analysis
11.1 Shire (Baxalta)
11.1.1 Company Details
11.1.2 Plasma Fractionation Product Offered
11.1.3 Shire (Baxalta) Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Shire (Baxalta) News
11.2 CSL
11.2.1 Company Details
11.2.2 Plasma Fractionation Product Offered
11.2.3 CSL Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 CSL News
11.3 Grifols
11.3.1 Company Details
11.3.2 Plasma Fractionation Product Offered
11.3.3 Grifols Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Grifols News
11.4 Octapharma
11.4.1 Company Details
11.4.2 Plasma Fractionation Product Offered
11.4.3 Octapharma Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Octapharma News
11.5 Kedrion
11.5.1 Company Details
11.5.2 Plasma Fractionation Product Offered
11.5.3 Kedrion Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Kedrion News
11.6 LFB Group
11.6.1 Company Details
11.6.2 Plasma Fractionation Product Offered
11.6.3 LFB Group Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 LFB Group News
11.7 Biotest
11.7.1 Company Details
11.7.2 Plasma Fractionation Product Offered
11.7.3 Biotest Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Biotest News
11.8 BPL
11.8.1 Company Details
11.8.2 Plasma Fractionation Product Offered
11.8.3 BPL Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 BPL News
11.9 RAAS
11.9.1 Company Details
11.9.2 Plasma Fractionation Product Offered
11.9.3 RAAS Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 RAAS News
11.10 CBPO
11.10.1 Company Details
11.10.2 Plasma Fractionation Product Offered
11.10.3 CBPO Plasma Fractionation Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 CBPO News
11.11 Hualan Bio
12 Research Findings and Conclusion
听
听
*If Applicable.